The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom

British Journal of Haematology

Volumn 162, Issue 3, 2013, Pages 400-408

  Zimbarra Cabrita, Inês ^a   Mohammed, Abubakar ^b   Layton, Mark ^b   Ghorashian, Sara ^b   Gilmore, Annette ^c   Cho, Gavin ^c   Howard, Jo ^d   Anie, Kofi A ^c   Desforges, Lynda ^e   Bassett, Paul ^f   Grapsa, Julia ^e   Howard, Luke ^a   Mahalingam, Gaia ^a   Dawson, David ^e   Pinto, Fausto J ^g   Nihoyannopoulos, Petros ^a   Davies, Sally C ^c,h   Gibbs, J Simon R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f Stats Consultancy   (United Kingdom)

^g HOSPITAL DE SANTA MARIA   (Portugal)

^h Department of Health ^*  (United Kingdom)

Author keywords

Mortality; Pulmonary hypertension; Sickle cell disease; Survival; Tricuspid regurgitation velocity

Indexed keywords

CREATINE; FERRITIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM DIAMETER; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HEART RIGHT ATRIUM VOLUME; HEMATOCRIT; HUMAN; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MITRAL VALVE DECELERATION TIME; MORTALITY; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; SURVIVAL RATE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE REGURGITATION VELOCITY; UNITED KINGDOM;

MORTALITY; PULMONARY HYPERTENSION; SICKLE CELL DISEASE; SURVIVAL; TRICUSPID REGURGITATION VELOCITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LONDON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRICUSPID VALVE INSUFFICIENCY; YOUNG ADULT;

EID: 84880252158     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12391     Document Type: Article

References (30)

1. Akgul, F., Yalcin, F., Seyfeli, E., Ucar, E., Karazincir, S., Balci, A. & Gali, E. (2007) Pulmonary hypertension in sickle-cell disease: comorbidities and echocardiographic findings. Acta Haematologica, 118, 53-60.
2. Anthi, A., Machado, R.F., Jison, M.L., Taveira-Dasilva, A.M., Rubin, L.J., Hunter, L., Hunter, C.J., Coles, W., Nichols, J., Avila, N.A., Sachdev, V., Chen, C.C. & Gladwin, M.T. (2007) Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 175, 1272-1279.
3. Ataga, K.I., Sood, N., De Gent, G., Kelly, E., Henderson, A.G., Jones, S., Strayhorn, D., Lail, A., Lieff, S. & Orringer, E.P. (2004) Pulmonary hypertension in sickle cell disease. The American Journal of Medicine, 117, 665-669.
4. Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. & Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. British Journal of Haematology, 134, 109-115.
5. Castro, O., Hoque, M. & Brown, B.D. (2003) Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 101, 1257-1261.
6. De Castro, L. (2004) Pulmonary hypertension in SS, SC and S thalassemia: prevalence, associated clinical syndromes, and mortality. Blood, 104, 462a.
7. De Castro, L.M., Jonassaint, J.C., Graham, F.L., Ashley-Koch, A. & Telen, M.J. (2008) Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. American Journal of Hematology, 83, 19-25.
8. Fitzhugh, C.D., Lauder, N., Jonassaint, J.C., Telen, M.J., Zhao, X., Wright, E.C., Gilliam, F.R. & De Castro, L.M. (2010) Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. American Journal of Hematology, 85, 36-40.
9. Fonseca, G.H., Souza, R., Salemi, V.M., Jardim, C.V. & Gualandro, S.F. (2012) Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. European Respiratory Journal, 39, 112-118.
10. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. The New England Journal of Medicine, 350, 886-895.
11. Gladwin, M.T., Barst, R.J., Gibbs, J.S.R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K.L., Little, J.A., Schraufnagel, D.E., Krishnamurti, L., Novelli, E.M., Girgis, R.E., Zhang, Y., Morris, C.R., Rosenzweig, E.B., Badesch, D.B., Lanzkron, S., Castro, O.L., Taylor, J.G., Goldsmith, J.C., Gordeuk, V.R., Kato, G.J. & Machado, R. (2012) Risk factors for death in 632 patients with sickle cell Anemia in the United States and United Kingdom. Blood (ASH Annual Meeting Abstracts), 120, 3240.
12. Gottdiener, J.S., Bednarz, J., Devereux, R., Gardin, J., Klein, A., Manning, W.J., Morehead, A., Kitzman, D., Oh, J., Quinones, M., Schiller, N.B., Stein, J.H. & Weissman, N.J. (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. Journal of the American Society of Echocardiography, 17, 1086-1119.
13. Hatle, L., Angelsen, B.A. & Tromsdal, A. (1981) Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. British Heart Journal, 45, 157-165.
14. Hickman, M., Modell, B., Greengross, P., Chapman, C., Layton, M., Falconer, S. & Davies, S.C. (1999) Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. British Journal of Haematology, 104, 860-867.
15. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., Picard, M.H., Roman, M.J., Seward, J., Shanewise, J.S., Solomon, S.D., Spencer, K.T., Sutton, M.S. & Stewart, W.J. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18, 1440-1463.
16. Lanzarini, L., Fontana, A., Lucca, E., Campana, C. & Klersy, C. (2002) Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure. American Heart Journal, 144, 1087-1094.
17. Lester, S.J., Tajik, A.J., Nishimura, R.A., Oh, J.K., Khandheria, B.K. & Seward, J.B. (2008) Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. Journal of the American College of Cardiology, 51, 679-689.
18. Liem, R.I., Young, L.T. & Thompson, A.A. (2007) Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica, 92, 1549-1552.
19. Lorch, D., Spevack, D. & Little, J. (2011) An elevated estimated pulmonary arterial systolic pressure, whenever measured, is associated with excess mortality in adults with sickle cell disease. Acta Haematologica, 125, 225-229.
20. Lucas, S.B., Mason, D.G., Mason, M. & Weyman, D. on behalf of NCEPOD. (2008) A sickle crisis? A report for the national confidential enquiry into patient outcome and death (NCEPOD). NCEPOD, London, UK.
21. Machado, R.F. & Gladwin, M.T. (2010) Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective. Chest, 137(Suppl. 6), 30S-38S.
22. Odd, B.-H., Nedim, S., Bengt, R. & Jonas, W. (2009) Doppler echocardiography can provide a comprehensive assessment of right ventricular afterload. Journal of the American Society of Echocardiography, 22, 1360-1367.
23. Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., Maitre, B., Yaici, A., Hajji, L., O'Callaghan, D.S., Clerson, P, .Girot, R., Galacteros, F. & Simonneau, G. (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. The New England Journal of Medicine, 365, 44-53.
24. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease - life expectancy and risk factors for early death. The New England Journal of Medicine, 330, 1639-1644.
25. Powars, D., Weidman, J.A., Odom-Maryon, T., Niland, J.C. & Johnson, C. (1988) Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore), 67, 66-76.
26. Quinn, C.T., Rogers, Z.R., McCavit, T.L. & Buchanan, G.R. (2010) Improved survival of children and adolescents with sickle cell disease. Blood, 115, 3447-3452.
27. Quinones, M.A., Otto, C.M., Stoddard, M., Waggoner, A. & Zoghbi, W.A. (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography, 15, 167-184.
28. Schultz, W.H. & Ware, R. (2003) Malignancy in patients with sickle cell disease. American Journal of Hematology, 74, 249-253.
29. Sutton, L.L., Castro, O., Cross, D.J., Spencer, J.E. & Lewis, J.F. (1994) Pulmonary hypertension in sickle cell disease. American Journal of Cardiology, 74, 626-628.
30. Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., Smalling, B., Amos, R., Stephens, A., Rogers, D. & Kirkham, F. (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica, 92, 905-912.